Nipocalimab in Early‐Onset Severe Hemolytic Disease of the Fetus and Newborn
Open Access
- 24 September 2026
- journal article
- research article
- Published by Wiley in Pediatric Discovery
- Vol. 4 (3) , e70067
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornNew England Journal of Medicine, 2024
- International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newbornBritish Journal of Haematology, 2022
- Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn – review on current management and outcomeExpert Review of Hematology, 2017
- Haemolytic disease of the fetus and newbornVox Sanguinis, 2015
- Hemolytic disease of the fetus and newborn: Current trends and perspectivesAsian Journal of Transfusion Science, 2011